OBJECTIVE: Cervical cancer is the second most common female cancer worldwide, and it remains a challenge to manage preinvasive and invasive lesions. Food-based cancer prevention entities, such as black raspberries and their derivatives, have demonstrated a marked ability to inhibit preclinical models of epithelial cancer cell growth and tumor formation. Here, we extend the role of black raspberry-mediated chemoprevention to that of cervical carcinogenesis. METHODS: Three human cervical cancer cell lines, HeLa (HPV16-/HPV18+, adenocarcinoma), SiHa (HPV16+/HPV18-, squamous cell carcinoma) and C-33A (HPV16-/HPV18-, squamous cell carcinoma), were treated with a lyophilized black raspberry ethanol extract (RO-ET) at 25, 50, 100 or 200μg/ml for 1, 3 and 5days, respectively. Cell proliferation was measured by WST1 (tetrazolium salt cleavage) assays. Flow cytometry (propidium iodide and Annexin V staining) and fluorescence microscopy analysis were used to measure apoptotic cell changes. RESULTS: We found that non-toxic levels of RO-ET significantly inhibited the growth of human cervical cancer cells, in a dose-dependent and time-dependent manner to a maximum of 54%, 52% and 67%, respectively (p<0.05). Furthermore, cell growth inhibition was persistent following short-term withdrawal of RO-ET from the culture medium. Flow cytometry and fluorescence microscopy demonstrated RO-ET-induced apoptosis in all cell lines. CONCLUSION: Black raspberries and their bioactive components represent promising candidates for future phytochemical-based mechanistic pathway-targeted cancer prevention strategies.
OBJECTIVE:Cervical cancer is the second most common female cancer worldwide, and it remains a challenge to manage preinvasive and invasive lesions. Food-based cancer prevention entities, such as black raspberries and their derivatives, have demonstrated a marked ability to inhibit preclinical models of epithelial cancer cell growth and tumor formation. Here, we extend the role of black raspberry-mediated chemoprevention to that of cervical carcinogenesis. METHODS: Three humancervical cancer cell lines, HeLa (HPV16-/HPV18+, adenocarcinoma), SiHa (HPV16+/HPV18-, squamous cell carcinoma) and C-33A (HPV16-/HPV18-, squamous cell carcinoma), were treated with a lyophilized black raspberry ethanol extract (RO-ET) at 25, 50, 100 or 200μg/ml for 1, 3 and 5days, respectively. Cell proliferation was measured by WST1 (tetrazolium salt cleavage) assays. Flow cytometry (propidium iodide and Annexin V staining) and fluorescence microscopy analysis were used to measure apoptotic cell changes. RESULTS: We found that non-toxic levels of RO-ET significantly inhibited the growth of humancervical cancer cells, in a dose-dependent and time-dependent manner to a maximum of 54%, 52% and 67%, respectively (p<0.05). Furthermore, cell growth inhibition was persistent following short-term withdrawal of RO-ET from the culture medium. Flow cytometry and fluorescence microscopy demonstrated RO-ET-induced apoptosis in all cell lines. CONCLUSION: Black raspberries and their bioactive components represent promising candidates for future phytochemical-based mechanistic pathway-targeted cancer prevention strategies.
Authors: Kapila A Rodrigo; Yeshwant Rawal; Robert J Renner; Steven J Schwartz; Qingguo Tian; Peter E Larsen; Susan R Mallery Journal: Nutr Cancer Date: 2006 Impact factor: 2.900
Authors: Navindra P Seeram; Lynn S Adams; Yanjun Zhang; Rupo Lee; Daniel Sand; Henry S Scheuller; David Heber Journal: J Agric Food Chem Date: 2006-12-13 Impact factor: 5.279
Authors: Nancy N Zikri; Kenneth M Riedl; Li-Shu Wang; John Lechner; Steven J Schwartz; Gary D Stoner Journal: Nutr Cancer Date: 2009 Impact factor: 2.900
Authors: Chaitali Ghosh; Julie A Baker; Kirsten B Moysich; Ruqayyah Rivera; John R Brasure; Susan E McCann Journal: Nutr Cancer Date: 2008 Impact factor: 2.900
Authors: Michele Follen; Frank L Meyskens; Ronald D Alvarez; Joan L Walker; Maria C Bell; Karen Adler Storthz; Jagannadha Sastry; Krishnendu Roy; Rebecca Richards-Kortum; Terri L Cornelison Journal: Cancer Date: 2003-11-01 Impact factor: 6.860
Authors: David E. Wedge; Kumudini M. Meepagala; James B. Magee; S. Hope Smith; George Huang; Lyndon L. Larcom Journal: J Med Food Date: 2001 Impact factor: 2.786
Authors: Stephen S Hecht; Chuanshu Huang; Gary D Stoner; Jingxia Li; Patrick M J Kenney; Shana J Sturla; Steven G Carmella Journal: Carcinogenesis Date: 2006-03-07 Impact factor: 4.944
Authors: Blake M Warner; Bruce C Casto; Thomas J Knobloch; Brent T Accurso; Christopher M Weghorst Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Date: 2014-09-16
Authors: Divya Nedungadi; Nathan Ryan; Kelvin Anderson; Felipe F Lamenza; Pete P Jordanides; Michael J Swingler; Liva Rakotondraibe; Kenneth M Riedl; Hans Iwenofu; Steve Oghumu Journal: Carcinogenesis Date: 2022-02-11 Impact factor: 4.944
Authors: Nathan M Ryan; Felipe F Lamenza; Puja Upadhaya; Hasan Pracha; Anna Springer; Michael Swingler; Arham Siddiqui; Steve Oghumu Journal: Front Immunol Date: 2022-08-09 Impact factor: 8.786
Authors: Thomas A Mace; Samantha A King; Zeenath Ameen; Omar Elnaggar; Gregory Young; Kenneth M Riedl; Steven J Schwartz; Steven K Clinton; Thomas J Knobloch; Christopher M Weghorst; Gregory B Lesinski Journal: Cancer Immunol Immunother Date: 2014-06-04 Impact factor: 6.968